Lightcalls.com
 

When it follows to the subject of ...

When it follows to the subject of immunostimulants, couple notable plant groups come to mind - echinacea (i.e., Echinacea angustifolia) and astragalus (i.e., Astragalus membranaceous), as well-as; not only-but also; not only-but; not alone-but of which are probably the best known immunostimulants generally available on the American market. Other medicinal plants of interest include Ganoderma (reishi) and other fungi. single in kind product category - generally notion of as energy herbs, adaptogens, or tonics - that is increasingly the subdue of research into immunostimulants is ginseng, including Asian ginseng (Panax ginseng) as well as Siberian ginseng (Eleutherococcus senticosus).

The couple researchers best known for their studies onward immunostimulatory medicinal plants are Professor Hildebert Wagner of the Institute of Pharmaceutical Biology, University of Munich; and Professor Rudolf Bauer of the Institute of Pharmaceutical Biology, Heinrich Heine University in Dusseldorf, Germany. As fate would have it, the day before I wrote this article, I happened to be with Dr Bauer and Dr Wagner in Orlando, Fla. at a special symposium entitled, "Phytomedicines of Europe" held as a satellite incident to the annual meeting of the American Chemical Society.

Wagner is widely considered to be the leading medicinal plant researcher in Europe His research arrange in Munich is world famous for its work upon immunostimulating herbs, particularly echinacea. Rudolph (Rudi) Bauer, a former pupil of Wagner, and a convenient friend over the years, is recognized as the world's leading researcher in succession echinacea. Having had the opportunity to devote a good deal of time with my friend, Rudi, throughout the past few days has given me the opportunity to learn what's just discovered and state of the art in echinacea research.



That's undivided of the exciting aspects of the medicinal plant field. The research field is not static in generating of recent origin information, even for herbs that have been used for centurys or thousands of years. There is always just discovered research that gives us a better understanding of the herbs' active constituents, best dosage forms, clinical applications, mechanisms of action, and in the same manner on. New information also helps us to dispel myths or anticipate at herbs in a of recent origin way that deepens our understanding of their use.

Biologically, what do

immunostimulants do for us?

According to Wagner and A. Proksch in a 1985 meditation from the University of Munich, immunostimulants are agents that stimulate the immune order in a nonspecific manner.

Phagocytosis on macrophages and granulocytes removes harmful bacteria and viruses. In other words, these immune small rooms "eat" invading pathogens (viruses and bacteria).

The powers of nonspecific immunostimulants fade relatively quickly, with equal reason they must be administered quite not seldom or continuously. As a arise of this intake schedule, they have been shown to help restore the body's susceptibility to infection, especially at the assault of colds and flus, as well as abate severity and duration of symptoms after gelids or flus have developed.

What's just discovered with echinacea?

Based upon Bauer's presentation at the American Chemical Society's "Phytomedicines of Europe" symposium, it is ironic to call echinacea a European phytomedicine. The genus Echinacea, which includes nine species, is native simply to North America.

In the historical literature, including many popular herbals in English to the ready day, E. angustifolia, is the mostly common species listed. Despite its popularity, there are no present clinical studies on this species. Clinical studies to date have demonstrated positive results for the expressed juice of novel flowering parts of Echinacea purpurea, as well as for alcoholic tinctures of Echinacea pallida and E purpurea roots

Bauer began looking at the chemistry and pharmacology of echinaceas in the mid- to late-1980s. From his work, it became clear that there was long confusion about the true source plants of echinacea, not no other than in commerce in the United States and Europe if it were not that also in the scientific literature. Now, primarily based onward Bauer's work, it is relatively easy to distinguish between echinacea species. He reports that, in Europe where through 500 echinacea products are now sold greatest in quantity preparations involve either the above-ground parts and/or the lower parts of E. purpurea, as well as the sources of E. angustifolia and E pallida, the latter of which has been historically confused with E angustifolia.

According to Bauer, the principally relevant compounds for immunostimulatory activity hang on the species used, plant part used, and model of preparation (organic solvents spiracles such as alcohol or water), and the different chemical composings found in each. Studies by dint of pharmacologists show that the immunostimulatory activity cannot be attributed to a single amalgamate or even a single class of unites For example, caffeic acid derivatives, glycoproteins (proteins limit to sugar) and lipopolysaccharides (carbohydrates/complex sugars limit to a lipid) have all been shown to stimulate the immune system



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.